Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $3,500 | 1 | 86.9% |
| Travel and Lodging | $323.61 | 3 | 8.0% |
| Food and Beverage | $175.82 | 5 | 4.4% |
| Education | $28.72 | 11 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Octapharma USA, Inc. | $3,964 | 7 | $0 (2019) |
| Allergan Inc. | $35.50 | 2 | $0 (2019) |
| Retrophin, Inc. | $18.74 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $4.74 | 1 | Travere Therapeutics, Inc. ($4.74) |
| 2022 | $1.66 | 2 | Travere Therapeutics, Inc. ($1.66) |
| 2020 | $3.58 | 4 | Travere Therapeutics, Inc. ($3.58) |
| 2019 | $3,985 | 11 | Octapharma USA, Inc. ($3,964) |
| 2018 | $33.22 | 2 | Allergan Inc. ($23.01) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/02/2023 | Travere Therapeutics, Inc. | Cholbam (Drug) | Education | In-kind items and services | $4.74 | General |
| Category: Hepatology | ||||||
| 10/05/2022 | Travere Therapeutics, Inc. | Cholbam (Drug) | Education | In-kind items and services | $0.83 | General |
| Category: Hepatology | ||||||
| 10/05/2022 | Travere Therapeutics, Inc. | Cholbam (Drug) | Education | In-kind items and services | $0.83 | General |
| Category: Hepatology | ||||||
| 02/25/2020 | Travere Therapeutics, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $0.96 | General |
| Category: Hepatology | ||||||
| 02/25/2020 | Travere Therapeutics, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $0.96 | General |
| Category: Hepatology | ||||||
| 02/25/2020 | Travere Therapeutics, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $0.83 | General |
| Category: Hepatology | ||||||
| 02/25/2020 | Travere Therapeutics, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $0.83 | General |
| Category: Hepatology | ||||||
| 11/13/2019 | Retrophin, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $6.87 | General |
| Category: Hepatology | ||||||
| 11/13/2019 | Retrophin, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $0.83 | General |
| Category: Hepatology | ||||||
| 06/12/2019 | Retrophin, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $0.83 | General |
| Category: Hepatology | ||||||
| 05/16/2019 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/27/2019 | Octapharma USA, Inc. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) | Honoraria | Cash or cash equivalent | $3,500.00 | General |
| Category: IMMUNOLOGY | ||||||
| 04/27/2019 | Octapharma USA, Inc. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) | Travel and Lodging | In-kind items and services | $191.37 | General |
| Category: IMMUNOLOGY | ||||||
| 04/27/2019 | Octapharma USA, Inc. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) | Food and Beverage | In-kind items and services | $69.48 | General |
| Category: IMMUNOLOGY | ||||||
| 04/27/2019 | Octapharma USA, Inc. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) | Travel and Lodging | In-kind items and services | $67.28 | General |
| Category: IMMUNOLOGY | ||||||
| 04/27/2019 | Octapharma USA, Inc. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) | Travel and Lodging | In-kind items and services | $64.96 | General |
| Category: IMMUNOLOGY | ||||||
| 04/27/2019 | Octapharma USA, Inc. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) | Food and Beverage | In-kind items and services | $38.01 | General |
| Category: IMMUNOLOGY | ||||||
| 04/27/2019 | Octapharma USA, Inc. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) | Food and Beverage | In-kind items and services | $32.83 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2018 | Retrophin, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $10.21 | General |
| Category: Hepatology | ||||||
| 07/17/2018 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: GASTROENTEROLOGY | ||||||
About Dr. Sydney Rice, MD
Dr. Sydney Rice, MD is a Developmental - Behavioral Pediatrics healthcare provider based in Tucson, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154403111.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sydney Rice, MD has received a total of $4,028 in payments from pharmaceutical and medical device companies, with $4.74 received in 2023. These payments were reported across 20 transactions from 4 companies. The most common payment nature is "Honoraria" ($3,500).
Practice Information
- Specialty Developmental - Behavioral Pediatrics
- Location Tucson, AZ
- Active Since 10/19/2006
- Last Updated 03/12/2009
- Taxonomy Code 2080P0006X
- Entity Type Individual
- NPI Number 1154403111
Products in Payments
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) $3,964
- LINZESS (Drug) $35.50
- (820) Cholbam (Drug) $22.32
- Cholbam (Drug) $6.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.